Match tier Listed
Presence Current · Arkansas
Last published 2024
Sources OpenAlex · ORCID
Refreshed 2026-08-15

Frits Vanrhee

Researcher

Also affiliated: University of Arkansas Medical Center (2012)

Unknown Researcher

4 h-index 9 pubs 344 cited

  • Humans
  • Multiple Myeloma
  • T-Lymphocytes
  • Immunotherapy, Adoptive
  • Aged
  • Retrospective Studies
  • Transplantation, Autologous
  • Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Blood Component Removal
  • Cell Survival
  • Flow Cytometry
  • Killer Cells, Natural
  • Lymphocyte Activation
  • Histocompatibility Antigens Class I

Biography and Research Information

OverviewAI-generated summary

Frits Vanrhee's research focuses on the outcomes of patients undergoing autologous stem cell transplantation, particularly those with IgD multiple myeloma. His work investigates demographic factors and treatment results within this patient population. Vanrhee has published research examining the characteristics and prognoses of older adults receiving these transplants. His scholarly contributions include a total of 9 publications, accumulating 339 citations, and an h-index of 4. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including Phillip Farmer, Clyde Bailey, and Nishanth Thalambedu, on shared publications.

Metrics

  • h-index: 4
  • Publications: 9
  • Citations: 344

Selected Publications

  • CLO24-090: Demographics and Outcomes of Autologous Stem Cell Transplant Among IgD Multiple Myeloma Patients (2024)
    Journal of the National Comprehensive Cancer Network DOI OpenAlex
  • Infection Risk Associated with Daratumumab (2017)
    Open Forum Infectious Diseases 4 citations DOI OpenAlex
  • An Outbreak of Respiratory Syncytial Virus Infections in an Outpatient Cancer Unit: Clinical Characteristics and Molecular Investigations (2016)
    Open Forum Infectious Diseases 1 citation DOI OpenAlex
  • Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured? (2012)
    Leukemia 115 citations DOI OpenAlex
  • CNTO 328, an Anti-Interleukin (IL)-6 Monoclonal Antibody (mAb) - Preliminary Results of Subjects with Castleman’s Disease from a Phase 1 Study in Selected Hematological Malignancies. (2006)
    Blood 2 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

8 Collaborators 1 Institution 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics